Insider Buys
This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Update Summary
- The city of Baltimore's trial, the largest nonparticipating subdivision, is set for September 2024. This could significantly impact litigation outcomes.
- The Uyghur Forced Labor Prevention Act, effective June 2023, may further disrupt operations and compliance costs. This could lead to increased operational expenses.
- Future goodwill impairment charges could adversely affect results, with past charges totaling $2.1 billion, $1.2 billion, and $675 million for fiscal years 2022, 2023, and 2024, respectively.
- Cardinal Health may incur additional costs due to climate change impacts, including increased repair costs and operational disruptions. This could negatively affect financial performance.
- The expiration of pharmaceutical distribution contracts with CVS Health and OptumRx could negatively impact revenue, as CVS accounted for 24% of fiscal 2024 revenue.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=721371&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.